Why the study?
To review pertinent studies on perioperative management of subcutaneous implantable cardioverter-defibrillators and explore potential approaches to minimizing periprocedural complications.
Does perioperative management prevent periprocedural complications in patients undergoing S-ICD placement?
Does perioperative management prevent periprocedural complications in patients undergoing S-ICD placement?
Extracardiac positioning of the S-ICD lowers lead-related complications and systemic infections, and specific perioperative management approaches can further minimize periprocedural risks like hematoma and postoperative pain.
Answers are grounded in this paper and cite their sources.
Optimizing S-ICD placement may reduce periprocedural complications; leaves open need for prospective validation.
The subcutaneous implantable cardioverter-defibrillator (S-ICD) is the latest option among devices clinically available for the prevention of sudden cardiac death, with experience from previous trials and postmarketing studies supporting the feasibility and safety of this kind of system. The extracardiac positioning of the S-ICD obviates the need for transvenous leads, which translates into lower incidence rates of lead-related complications and systemic infections. This review will highlight the results of pertinent studies related to the perioperative management of S-ICDs and review potential approaches to minimizing the risk of complications such as hematoma at the pulse generator location, unsuccessful defibrillation due to suboptimal S-ICD lead and generator positioning, and postoperative pain. An extensive literature search using PubMed was conducted to identify relevant articles.
No takes yet. Share an insight, caveat, or question.
Vedachalam et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: